查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612262

天冬酰胺市场：按类型、应用分类 - 2025-2030 年全球预测

Asparagine Market by Type (Asparagine Anhydrous, Asparagine Monohydrate), Application (Food & Beverage, Pharmaceutical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年天门冬胺酸市场价值为118.1亿美元，预计到2024年将达到124亿美元，复合年增长率为5.29%，预计到2030年将达到169.6亿美元。

天冬酰胺是一种非必需氨基酸，对于蛋白质合成和代谢调节等多种生理过程至关重要。它存在于植物和动物中，最常见于芦笋，它的名字也由此而来，对于维持细胞功能和生物合成糖蛋白是必需的。它具有广泛的用途，包括食品和饮料、药品和营养食品，有助于促进细胞功能和维持神经系统的健康。近年来，随着注重健康的消费趋势，对胺基酸补充品和机能性食品的需求不断增加，推动了天冬酰胺市场的成长。趋势表明，健康疾病盛行率的上升和健康老化的成长趋势带来了巨大的市场机会。公司可以透过配製富含天冬酰胺的产品来探索产品创新，以满足从运动员到老年人等不同人群的饮食和健康需求。然而，严格的法律规范和来自替代氨基酸的竞争构成了限制市场扩张的挑战。此外，原材料价格的波动和消费者对市场动态固有利益的认识有限，进一步使市场动态变得更加复杂。创新机会在于探索天冬酰胺合成和应用的生物技术进步，并有可能在医疗和机能性食品领域发现新的应用。市场参与企业应注重研发倡议，以提高天冬酰胺的生物利用度和功效，同时促进与研究机构的合作，以引领氨基酸研究的突破。鑑于天冬酰胺的强大作用，公司可以利用洁净标示和植物来源饮食等新的消费趋势，透过提供符合永续实践的产品来参与竞争。整体而言，市场格局很微妙，需要对监管环境和消费者教育进行策略引导，以充分发挥其潜力。

主要市场统计
基准年[2023] 118.1亿美元
预计年份 [2024] 124亿美元
预测年份 [2030] 169.6亿美元
复合年增长率（%） 5.29%

市场动态：揭示快速发展的天冬酰胺市场的关键市场洞察

天冬酰胺市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 健康意识不断增强，对营养食品的需求不断增加
    • 加大医药产业研发投入
    • 食品饮料产业持续创新
  • 市场限制因素
    • 原物料价格波动
  • 市场机会
    • 开发含有天冬酰胺的新配方
    • 精准医学和标靶治疗的兴起
  • 市场问题
    • 关于天冬酰胺使用的严格法规和标准

波特的五力：驾驭天冬酰胺市场的策略工具

波特的五力框架是了解天冬酰胺市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解天冬胺酸市场的外部影响

外部宏观环境因素在塑造天冬酰胺市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解天冬酰胺市场的竞争格局

对天冬酰胺市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：天门冬胺酸市场供应商绩效评估

FPNV定位矩阵是评估天门冬胺酸市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划天冬酰胺市场的成功之路

天冬酰胺市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 健康意识不断增强，对营养食品的需求不断提高
      • 加大医药产业研发投入
      • 食品饮料产业持续创新
    • 抑制因素
      • 原物料价格波动
    • 机会
      • 开发含有天冬酰胺的新药物製剂。
      • 精准医学和标靶治疗的兴起
    • 任务
      • 严格的天冬酰胺使用法规和标准
  • 市场区隔分析
    • 类型：干燥混合营养素配方中对无水天冬酰胺的需求不断增加
    • 用途：增加天冬酰胺的使用以增强产品的营养价值和风味
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章天冬酰胺市场：依类型

  • 介绍
  • 无水天冬酰胺
  • 天门冬胺酸一水化合物

第七章天冬酰胺市场：依应用分类

  • 介绍
  • 饮食
  • 製药

第八章 美洲天冬胺市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太天冬胺市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲天冬胺市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Jazz Pharmaceuticals 的 Enrylase（重组欧文氏菌天冬Asparaginase或 Crisantaspase）获得欧盟委员会核准用于治疗急性淋巴性白血病和淋巴细胞淋巴瘤
    • 凯米斯新材料与Bicells建设2000吨/年L-天冬酰胺计划及100吨/年GABA计划
  • 战略分析和建议

公司名单

  • BioVendor Group
  • Creative Enzymes
  • Duchefa Biochemie BV
  • Jazz Pharmaceuticals, Inc.
  • LGC Limited
  • medac GmbH
  • Merck KGaA
  • MP Biomedicals, LLC
  • Porton Biopharma Limited
  • Taj Pharmaceuticals Ltd.
  • Tokyo Chemical Industry (India) Pvt. Ltd.
  • VWR International, LLC
Product Code: MRR-C1290E70D506

The Asparagine Market was valued at USD 11.81 billion in 2023, expected to reach USD 12.40 billion in 2024, and is projected to grow at a CAGR of 5.29%, to USD 16.96 billion by 2030.

Asparagine is a non-essential amino acid integral to various physiological processes, including protein synthesis and metabolic regulation. It is found in plant and animal sources, commonly in asparagus from which it derives its name, and is necessary for maintaining cellular function and the biosynthesis of glycoproteins. Its application spans across food and beverage, pharmaceuticals, and nutritional supplements, driven by its role in promoting cellular operations and maintaining neurological health. In recent years, the asparagine market has witnessed growth fueled by an increasing demand for amino acid-based supplements and functional foods in line with health-conscious consumer trends. Insights indicate that the rising prevalence of health disorders and the growing trend of healthy aging present significant market opportunities. Companies can explore product innovation by formulating asparagine-enriched products catering to the dietary and wellness needs of varied demographics, from athletes to the aging population. However, stringent regulatory frameworks, coupled with competition from alternative amino acids, pose challenges that may restrain market expansion. Moreover, fluctuating raw material prices and limited consumer awareness of asparagine-specific benefits further complicate market dynamics. Innovation opportunities lie in the exploration of biotechnological advancements in asparagine synthesis and application, potentially uncovering new uses in the medical and functional foods arena. Market participants should focus on R&D initiatives that enhance the bioavailability and efficacy of asparagine while also fostering collaborations with research institutions to spearhead breakthroughs in amino acid studies. Given its potent role, businesses can gain a competitive edge by leveraging emerging consumer trends such as clean labeling and plant-based diets, adapting their offerings to align with sustainable practices. Overall, the market for asparagine is nuanced, requiring strategic navigation of regulatory landscapes and consumer education to unlock its potential fully.

KEY MARKET STATISTICS
Base Year [2023] USD 11.81 billion
Estimated Year [2024] USD 12.40 billion
Forecast Year [2030] USD 16.96 billion
CAGR (%) 5.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Asparagine Market

The Asparagine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising health consciousness and demand for dietary supplements
    • Increased investment for R&D in pharmaceutical industry
    • Ongoing innovations in the food and beverage industry
  • Market Restraints
    • Fluctuations in prices of raw materials
  • Market Opportunities
    • Development of novel pharmaceutical formulations containing asparagine.
    • Rise in precision medicine and targeted therapies
  • Market Challenges
    • Stringent regulations and standards regarding the use of asparagine

Porter's Five Forces: A Strategic Tool for Navigating the Asparagine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Asparagine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Asparagine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Asparagine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Asparagine Market

A detailed market share analysis in the Asparagine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Asparagine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Asparagine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Asparagine Market

A strategic analysis of the Asparagine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.

Market Segmentation & Coverage

This research report categorizes the Asparagine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Asparagine Anhydrous and Asparagine Monohydrate.
  • Based on Application, market is studied across Food & Beverage and Pharmaceutical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising health consciousness and demand for dietary supplements
      • 5.1.1.2. Increased investment for R&D in pharmaceutical industry
      • 5.1.1.3. Ongoing innovations in the food and beverage industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel pharmaceutical formulations containing asparagine.
      • 5.1.3.2. Rise in precision medicine and targeted therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards regarding the use of asparagine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type:Growing demand for Anhydrous asparagine in dry-blending nutritional formulations
    • 5.2.2. Application: Rising usage of Asparagine for enhancing nutritional value and flavor profiles of products
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Asparagine Market, by Type

  • 6.1. Introduction
  • 6.2. Asparagine Anhydrous
  • 6.3. Asparagine Monohydrate

7. Asparagine Market, by Application

  • 7.1. Introduction
  • 7.2. Food & Beverage
  • 7.3. Pharmaceutical

8. Americas Asparagine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asparagine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Asparagine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    • 11.3.2. Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioVendor Group
  • 2. Creative Enzymes
  • 3. Duchefa Biochemie B.V.
  • 4. Jazz Pharmaceuticals, Inc.
  • 5. LGC Limited
  • 6. medac GmbH
  • 7. Merck KGaA
  • 8. MP Biomedicals, LLC
  • 9. Porton Biopharma Limited
  • 10. Taj Pharmaceuticals Ltd.
  • 11. Tokyo Chemical Industry (India) Pvt. Ltd.
  • 12. VWR International, LLC

LIST OF FIGURES

  • FIGURE 1. ASPARAGINE MARKET RESEARCH PROCESS
  • FIGURE 2. ASPARAGINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ASPARAGINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ASPARAGINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASPARAGINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ASPARAGINE MARKET DYNAMICS
  • TABLE 7. GLOBAL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ASPARAGINE MARKET SIZE, BY ASPARAGINE ANHYDROUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ASPARAGINE MARKET SIZE, BY ASPARAGINE MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ASPARAGINE MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ASPARAGINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023